Exagen Inc. - Autoimmune Disease Testing Lab - Rheumatology Lab

Time 2022-07-26 00:43:32

Web Name: Exagen Inc. - Autoimmune Disease Testing Lab - Rheumatology Lab

WebSite: http://www.exagen.com

ID:260312

Keywords:

Autoimmune,Inc,Exagen,Disease

Description:

This is a website for healthcare professionals.

View Patient WebsiteContact UsOur ProductsAVISE CTDSLE & Connective Tissue Disease TestAVISE LupusSLE Diagnostic TestAVISE SLE MonitorSLE Disease Monitoring TestAVISE SLE PrognosticSLE Prognostic TestAVISE APSAntiphospholipid Syndrome TestAVISE MTXMethotrexate Polyglutamate Measuring TestAVISE HCQThe Hydroxychloroquine (HCQ) test measuring drug levels in whole bloodAVISE TouchLow volume specimen collection deviceAVISE Vasculitis AAVAVISE Anti-CarPAVISE PC4dHistory of SLE ThrombosisOur ScienceCB-CAPs – Lupus BiomarkersResearch & DevelopmentAVISE RADRPublicationsAVISE CTD / AVISE Lupus / AVISE CB-CAPsAVISE SLE Monitor / AVISE PC4dAVISE MTX / AVISE TouchAVISE HCQ / AVISE TouchSelected AbstractsInvestorsInvestor OverviewPress ReleasesEventsESGCorporate GovernanceESG ReportsPresentationsSEC FilingsStock InformationCorporate GovernanceInvestor FAQsAnalyst CoverageInvestor ContactsEmail AlertsBusiness DevelopmentBusiness DevelopmentBioPharma ServicesPartnersAboutAbout ExagenExagen QualityOur PeopleLeadershipBoard of DirectorsCareersLab CertificationsResourcestelAVISE Draw Site LocatorPay BillInsurance & BillingAVISE Tests

Research & Development
Personalized Rule-In Drug Response Test for RA Therapies

Exagen Inc. is collaborating with Queen Mary University of London to develop a personalized therapeutic agent selection test for RA patients.

Therapeutic agent selection for RA patients remains a significant unmet need.  Our science will better inform healthcare providers on patients’ prognosis and enhance their ability to make informed decisions on drug prescribing.

“Exagen is committed to developing and commercializing these assays to inform treatment decisions throughout the RA patient journey. We intend to market the new assays as AVISE® RADR (rheumatoid arthritis drug response),” said Ron Rocca, President and CEO of Exagen Inc.

---

Learn more about AVISE® RADR

×

COVID – 19 Update

“To Physicians, Patients, and valued Partners, thank you for visiting our website. Like many of you, theCOVID-19 pandemic has impacted the way we work and live. As a critically important company for autoimmune disorders, we wanted to inform you that our laboratory remains fully functional as we address the needs of patients with our Diagnostics, Prognostics, Monitoring, and at home self-administered anti-TNF therapeutic.

This outbreak reminds us that we’re all connected. At Exagen, our mission is clear to offer solutions to address the medical needs of our community. On behalf of all of us at Exagen, we’re committed to being your partner and persevering together in all the days and years ahead.”– Ron Rocca President and CEO, Exagen Inc.

For more information, please call 888.452.1522 or emailinfo@exagen.com. Clickhereto learn how to access an AVISE test.

Exagen Inc.

Patient Focused.Discovery Driven.

---

Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company. We aid patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions.Our relentless pursuit for laboratory excellence has enabled us to develop next-generation autoimmune testing to help empower physicians and improve patients' lives.

---

About Exagen

Exagen provides physicians with advanced testing for accurate and timely diagnosis, prognosis and monitoring of autoimmune conditions.Learn More

---

Our Products

AVISE testing offers next-generation insight to aid the treatment of autoimmune conditions.Learn More

---

Press Releases

Stay up to date with breaking news, events and product development.Learn More

---

Iusto definitiones ei mei, exerci iracundia ad vel. Has in elit aliquam, ius consul scripta vocibus id.

---

Learn More

---

Iusto definitiones ei mei, exerci iracundia ad vel. Has in elit aliquam, ius consul scripta vocibus id.

---

Learn More

---

Iusto definitiones ei mei, exerci iracundia ad vel. Has in elit aliquam, ius consul scripta vocibus id.

---

Learn More

---

Iusto definitiones ei mei, exerci iracundia ad vel. Has in elit aliquam, ius consul scripta vocibus id.

---

Learn More

---

Proud Exagen Partners Our Products← BackAVISE CTD← BackSLE & Connective Tissue Disease TestAVISE Lupus← BackSLE Diagnostic TestAVISE SLE Monitor← BackSLE Disease Monitoring TestAVISE SLE Prognostic← BackSLE Prognostic TestAVISE APS← BackAntiphospholipid Syndrome TestAVISE MTX← BackMethotrexate Polyglutamate Measuring TestAVISE HCQ← BackThe Hydroxychloroquine (HCQ) test measuring drug levels in whole bloodAVISE Touch← BackLow volume specimen collection deviceAVISE Vasculitis AAVAVISE Anti-CarPAVISE PC4d← BackHistory of SLE ThrombosisOur Science← BackCB-CAPs – Lupus BiomarkersResearch & Development← BackAVISE RADRPublications← BackAVISE CTD / AVISE Lupus / AVISE CB-CAPsAVISE SLE Monitor / AVISE PC4dAVISE MTX / AVISE TouchAVISE HCQ / AVISE TouchSelected AbstractsInvestors← BackInvestor OverviewPress ReleasesEventsESG← BackCorporate GovernanceESG ReportsPresentationsSEC FilingsStock InformationCorporate GovernanceInvestor FAQsAnalyst CoverageInvestor ContactsEmail AlertsBusiness Development← BackBusiness DevelopmentBioPharma ServicesPartnersAbout← BackAbout ExagenExagen QualityOur People← BackLeadershipBoard of DirectorsCareersLab CertificationsResources← BacktelAVISE Draw Site LocatorPay BillInsurance & BillingAVISE TestsTerms of UseNotice of Privacy PracticesCalifornia Data NoticeLab CertificationsContact Us

TAGS:Autoimmune Inc Exagen Disease

<<< Thank you for your visit >>>

Hot Websites